Development of a diagnostic sensor for measuring blood cell concentrations during haemoconcentration

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: HemoSep® is a commercial ultrafiltration and haemoconcentration device for the concentration of residual bypass blood following surgery. This technology is capable of reducing blood loss in cardiac and other types of "clean site" procedures, including paediatric surgery. Clinical feedback suggested that the device would be enhanced by including a sensor technology capable of discerning the concentration level of the processed blood product. We sought to develop a novel sensor that can, using light absorption, give an accurate estimate of packed cell volume (PCV).
Materials and methods: A sensor-housing unit was 3D printed and the factors influencing the sensor's effectiveness – supply voltage, sensitivity and emitter intensity - were optimised. We developed a smart system, using comparator circuitry capable of visually informing the user when adequate PCV levels (⩾35%) are attained by HemoSep® blood processing, which ultimately indicates that the blood is ready for autotransfusion.
Results: Our data demonstrated that the device was capable of identifying blood concentration at and beyond the 35% PCV level. The device was found to be 100% accurate at identifying concentration levels of 35% from a starting level of 20%.
Discussion: The sensory capability was integrated into HemoSep's® current device and is designed to enhance the user’s clinical experience and to optimise the benefits of HemoSep® therapy. The present study focused on laboratory studies using bovine blood. Further studies are now planned in the clinical setting to confirm the efficacy of the device.
LanguageEnglish
Number of pages7
JournalPerfusion
Early online date2 Sep 2016
DOIs
Publication statusE-pub ahead of print - 2 Sep 2016

Fingerprint

surgery
Blood Cells
diagnostic
Blood
Cells
Sensors
Equipment and Supplies
Cell Size
housing
supply
Surgery
experience
Technology
Autologous Blood Transfusions
Pediatrics
Ultrafiltration
Light absorption
Feedback
Electric potential
Processing

Keywords

  • haemoconcentration
  • autotransfusion
  • packed cell volume
  • haematocrit
  • light sensor

Cite this

@article{97cb4af3282e41689b4939e1ef35009b,
title = "Development of a diagnostic sensor for measuring blood cell concentrations during haemoconcentration",
abstract = "Background: HemoSep{\circledR} is a commercial ultrafiltration and haemoconcentration device for the concentration of residual bypass blood following surgery. This technology is capable of reducing blood loss in cardiac and other types of {"}clean site{"} procedures, including paediatric surgery. Clinical feedback suggested that the device would be enhanced by including a sensor technology capable of discerning the concentration level of the processed blood product. We sought to develop a novel sensor that can, using light absorption, give an accurate estimate of packed cell volume (PCV).Materials and methods: A sensor-housing unit was 3D printed and the factors influencing the sensor's effectiveness – supply voltage, sensitivity and emitter intensity - were optimised. We developed a smart system, using comparator circuitry capable of visually informing the user when adequate PCV levels (⩾35{\%}) are attained by HemoSep{\circledR} blood processing, which ultimately indicates that the blood is ready for autotransfusion.Results: Our data demonstrated that the device was capable of identifying blood concentration at and beyond the 35{\%} PCV level. The device was found to be 100{\%} accurate at identifying concentration levels of 35{\%} from a starting level of 20{\%}. Discussion: The sensory capability was integrated into HemoSep's{\circledR} current device and is designed to enhance the user’s clinical experience and to optimise the benefits of HemoSep{\circledR} therapy. The present study focused on laboratory studies using bovine blood. Further studies are now planned in the clinical setting to confirm the efficacy of the device.",
keywords = "haemoconcentration, autotransfusion, packed cell volume, haematocrit, light sensor",
author = "Robertson, {Craig A.} and Terence Gourlay",
year = "2016",
month = "9",
day = "2",
doi = "10.1177/0267659116667806",
language = "English",
journal = "Perfusion",
issn = "0267-6591",

}

TY - JOUR

T1 - Development of a diagnostic sensor for measuring blood cell concentrations during haemoconcentration

AU - Robertson, Craig A.

AU - Gourlay, Terence

PY - 2016/9/2

Y1 - 2016/9/2

N2 - Background: HemoSep® is a commercial ultrafiltration and haemoconcentration device for the concentration of residual bypass blood following surgery. This technology is capable of reducing blood loss in cardiac and other types of "clean site" procedures, including paediatric surgery. Clinical feedback suggested that the device would be enhanced by including a sensor technology capable of discerning the concentration level of the processed blood product. We sought to develop a novel sensor that can, using light absorption, give an accurate estimate of packed cell volume (PCV).Materials and methods: A sensor-housing unit was 3D printed and the factors influencing the sensor's effectiveness – supply voltage, sensitivity and emitter intensity - were optimised. We developed a smart system, using comparator circuitry capable of visually informing the user when adequate PCV levels (⩾35%) are attained by HemoSep® blood processing, which ultimately indicates that the blood is ready for autotransfusion.Results: Our data demonstrated that the device was capable of identifying blood concentration at and beyond the 35% PCV level. The device was found to be 100% accurate at identifying concentration levels of 35% from a starting level of 20%. Discussion: The sensory capability was integrated into HemoSep's® current device and is designed to enhance the user’s clinical experience and to optimise the benefits of HemoSep® therapy. The present study focused on laboratory studies using bovine blood. Further studies are now planned in the clinical setting to confirm the efficacy of the device.

AB - Background: HemoSep® is a commercial ultrafiltration and haemoconcentration device for the concentration of residual bypass blood following surgery. This technology is capable of reducing blood loss in cardiac and other types of "clean site" procedures, including paediatric surgery. Clinical feedback suggested that the device would be enhanced by including a sensor technology capable of discerning the concentration level of the processed blood product. We sought to develop a novel sensor that can, using light absorption, give an accurate estimate of packed cell volume (PCV).Materials and methods: A sensor-housing unit was 3D printed and the factors influencing the sensor's effectiveness – supply voltage, sensitivity and emitter intensity - were optimised. We developed a smart system, using comparator circuitry capable of visually informing the user when adequate PCV levels (⩾35%) are attained by HemoSep® blood processing, which ultimately indicates that the blood is ready for autotransfusion.Results: Our data demonstrated that the device was capable of identifying blood concentration at and beyond the 35% PCV level. The device was found to be 100% accurate at identifying concentration levels of 35% from a starting level of 20%. Discussion: The sensory capability was integrated into HemoSep's® current device and is designed to enhance the user’s clinical experience and to optimise the benefits of HemoSep® therapy. The present study focused on laboratory studies using bovine blood. Further studies are now planned in the clinical setting to confirm the efficacy of the device.

KW - haemoconcentration

KW - autotransfusion

KW - packed cell volume

KW - haematocrit

KW - light sensor

UR - http://prf.sagepub.com/

U2 - 10.1177/0267659116667806

DO - 10.1177/0267659116667806

M3 - Article

JO - Perfusion

T2 - Perfusion

JF - Perfusion

SN - 0267-6591

ER -